Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/02/2010US20100305140 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/02/2010US20100305138 Pyridyl derivatives and their use as therapeutic agents
12/02/2010US20100305137 Piperazine derivatives and methods of use
12/02/2010US20100305133 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305128 Pyrimidinyl-Thiophene Kinase Modulators
12/02/2010US20100305127 Novel compounds
12/02/2010US20100305124 Acylated Aminopyridine and Aminopyridazine Insecticides
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305118 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305099 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305090 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
12/02/2010US20100305088 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010US20100305065 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
12/02/2010US20100304074 Indolium compound and optical recording material containing the same
12/02/2010DE102009022895A1 Substituierte Piperidine Substituted piperidines
12/02/2010CA2763700A1 2, 4-diamino pyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010CA2763633A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763498A1 Pyrazinylpyrazoles
12/02/2010CA2763381A1 Substituted piperidines
12/02/2010CA2763370A1 Substituted piperidines
12/02/2010CA2762885A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010CA2762347A1 Substituted quinazolines as fungicides
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256112A1 Anthranilamides, process for the production thereof and pest controllers containing the same
12/01/2010EP2256108A1 Substituted triazine kinase inhibitors
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
12/01/2010EP2254883A1 Substituted indole derivatives
12/01/2010EP2254867A1 Substituted sulfonamide derivatives
12/01/2010EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
12/01/2010EP2029574B1 Novel method for preparation of ammonium salts of esomeprazole
12/01/2010EP2004604B1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
12/01/2010EP1590336B1 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN1993353B Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/01/2010CN1989125B 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi
12/01/2010CN101903378A Aminotriazole derivatives
12/01/2010CN101903376A Processes and intermediates for producing aminobenzimidazole ureas
12/01/2010CN101903375A Carboxyl- or hydroxyl-substituted benzimidazole derivatives
12/01/2010CN101903374A 2-benzylpyridazinone derivatives as met kinase inhibitors
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903372A Heteroaryl derivatives as orexin receptor antagonists
12/01/2010CN101903371A Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101903355A Novel imidazole-substituted arylamides
12/01/2010CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903348A Novel pyrazole-substituted arylamides
12/01/2010CN101903347A Piperidinyl and piperazinyl modulators of gamma-secretase
12/01/2010CN101903343A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899036A Method for preparing sertindole by using alkyl imidazole type ionic liquid as solvent
12/01/2010CN101899035A Preparation method of high-purity imatinib
12/01/2010CN101899013A 2-(2-substituted aryl-2H-1,2,4-triazole-3-sulfydryl) acetamide derivative and preparation method and application thereof
12/01/2010CN101899010A Quinazol derivative, preparation method and application thereof
12/01/2010CN101899007A Pyridine compound
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
12/01/2010CN101548974B Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof
12/01/2010CN101475562B Method for synthesizing lansoprazole and salt thereof
12/01/2010CN101402644B Production method for metal aza ring carbene complex
12/01/2010CN101115737B Novel salt form of a dopamine agonist
11/2010
11/30/2010US7842820 Sulfonylpyrroles
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842707 Peptidase inhibitors
11/30/2010US7842706 Pharmaceutical composition
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842695 such as 1-{1-[5-(4-Fluorophenyl)pyridin-2-yl]-5-furan-2-yl-1H-pyrazol-4-ylmethyl}-4-methylpiperazine, exhibiting selective serotonin receptor antagonistic properties, used for the prophylaxis and/or treatment of psychoses, neurological disorders, amyotrophic lateral sclerosis, eating and vision disorders
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010US7842688 Organic compounds
11/30/2010CA2607499C Histamine-3 receptor antagonists
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2515151C Non-nucleoside reverse transcriptase inhibitors
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2315693C Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
11/25/2010WO2010135506A1 Process for the preparation of 4- [6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino) -5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010WO2010135505A2 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010WO2010134533A1 2,4-diaminopyrimidine compound having aminocyclohexylalkyl group
11/25/2010WO2010134099A1 One pot process for preparing omeprazole and related compounds
11/25/2010WO2010133976A2 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
11/25/2010WO2010133885A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010WO2010133748A1 Protease inhibitors
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 1080